December Public Offerings: Biotechs and EV Company Report
Tap title to read story
United States. Several companies announced or completed public equity offerings this week. On Dec. 9 Terns Pharmaceuticals filed for a proposed $400 million offering with a 30-day option for $60 million, and Denali Therapeutics filed for a $200 million offering with a $30 million option. On Dec. 11 Blink Charging priced 26,666,666 shares at $0.75 raising about $20 million, Tenaya Therapeutics filed to offer units, and on Dec. 11 Terns and Dyne Therapeutics closed upsized offerings raising roughly $747.5 million and $402.5 million respectively. Underwriters and SEC filings accompanied the announcements. Based on 7 articles reviewed independently and supporting research.
More context
Timeline
- 1. Dec. 9, 2025 — Terns announces proposed $400M offering and $60M option.
- 2. Dec. 9, 2025 — Denali Therapeutics announces proposed $200M offering and $30M option.
- 3. Dec. 10, 2025 — SEC declares Blink Charging registration effective (Form S-1).
- 4. Dec. 11, 2025 — Blink prices 26,666,666 shares at $0.75 per share.
- 5. Dec. 11, 2025 — Terns and Dyne close offerings, reporting $747.5M and $402.5M gross proceeds.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
